@jumal13 Profile picture

Juan Manuel Aldana

@jumal13

Joined August 2011
Similar User
motilidad photo

@motilidad

VELARDEMD photo

@velardemd

Graciela Castro Narro photo

@GCastro_NarroMD

NICOLAS FERNANDEZ photo

@NicolasFdz_

Aldo J. Montano-Loza photo

@aldomontanoloza

Santino García-Jiménez photo

@e_santino

Luis Valdovinos, MD, MSc photo

@drprapul

Enrique Coss photo

@coss_enriquemd

Jose Luis Pérez Hernández photo

@JoseLuisPrezHe7

Octavio Gomez-Escudero photo

@octavio_gomezmd

Alejandra Noble photo

@alenoblel

Lissa M Cruz photo

@LM_CruzMD

Dr. Genaro Vázquez-Elizondo, AGAF photo

@GastroMty

Pepe Velarde photo

@PepeVelarde2

MaBiFer photo

@asleibm

Juan Manuel Aldana Reposted

ARTÍCULO ORIGINAL Efectos hemodinámicos de carvedilol más simvastatina en cirrosis con hipertensión portal severa y respuesta subóptima a bloqueadores β: Un ensayo aleatorizado, doble ciego, controlado con placebo Alvarado-Tapias et al. #LiverX tinyurl.com/2trhbnub

Tweet Image 1

Juan Manuel Aldana Reposted

🚨New guidelines for endoscopy in #ChronicPancreatitis by @ASGEendoscopy! 🔑: ▶️PD stricture? the largest plastic stent ▶️PD stones>5 mm? ESWL/EHL ▶️Biliary stricture? ERCP - FCSEMS ▶️Symptomatic pseudocyst? EUS drainage #pancreatology #AdvancedEndoscopy #GIFellow

Tweet Image 1
Tweet Image 2
Tweet Image 3
Tweet Image 4

Juan Manuel Aldana Reposted

Relative/Absolute Contraindications for Choice of Treatment in IBD ▪️Latent TB ▪️Chronic hepatitis B ▪️Melanoma ▪️Anti-drug antibodies to first TNFi ▪️Uveitis & Macular Edema ▪️Type 2 heart block ▪️Personal hx or FDR w/ Lymphoma ▪️Smokers, age >65, other CV/CAD risks #ACG2024

Tweet Image 1

Juan Manuel Aldana Reposted

Lifestyle modifications that reduce the risk of RECURRENT DIVERTICULITIS 1️⃣ BMI 18-25 2️⃣ Red meat <4x/week 3️⃣ ≥ 23 g fiber / day 4️⃣ Exercise 2hr/week 5️⃣ No smoking Account for 50% of population attributable risk! #ACG2024

Tweet Image 1

Juan Manuel Aldana Reposted

🆕 @AmCollegeGastro Eosinophilic Esophagitis Guideline (in press soon) Algorithm for EoE Management #ACG2024

Tweet Image 1

Juan Manuel Aldana Reposted

Series on Colon Polypectomy

Tweet Image 1

Juan Manuel Aldana Reposted

In today's #readoftheweek📚, learn why proton pump inhibitor use is not associated with a higher risk of hepatic encephalopathy in patients with #cirrhosis. Read this @JHEP_Reports article: jhep-reports.eu/article/S2589-… 🙏@c_labenz, @SJGairing, @MontagneseSara et al. #LiverTwitter

Tweet Image 1

Juan Manuel Aldana Reposted

Perioperative management of DOACs 📌 📸: jamanetwork.com/journals/jama/…

Tweet Image 1

Juan Manuel Aldana Reposted

Alcohol is extra toxic to the liver after bariatric surgery because of decreased metabolism of ethanol by the bypassed stomach Screen for binge drinking in people who are undergoing or have received bariatric surgery journals.lww.com/hepcomm/fullte…

Tweet Image 1

Juan Manuel Aldana Reposted

📢Check our August issue ‼️ 💥Featured article: EASL position paper on clinical follow-up after HCV cure🔗bit.ly/3Va2uh2 Full issue here👉bit.ly/36khmDF #LiverTwitter @ProfPaoloAngeli @EASLedu @EASLnews

Tweet Image 1

Juan Manuel Aldana Reposted

A succinct review on management of hepatitis B reactivation. Risks and decision for prophylaxis are based on serologic status of patients and type of immunosuppressive therapy. Helpful figure to guide decision making. journals.lww.com/cld/fulltext/2…


Juan Manuel Aldana Reposted

Hepatitis inmunomediada: conceptos básicos y tratamiento Gran colaboración 🎉🎉💪🏻con el equipo de @DrJavierCrespo y nuestro hospital @e_santino @jumal13 @PepeVelarde2 @DianaTapiaCK sciencedirect.com/science/articl…


Juan Manuel Aldana Reposted

Hepatitis inmunomediada: conceptos básicos y tratamiento. Que suerte y qué honor haber podido trabajar con amigos y expertos como @e_santino @jumal13 @PepeVelarde2 @DianaTapiaCK @adiazgonzalezMD y @velardemd @sepdigestiva @AEEHLiver Espero que os guste. sciencedirect.com/science/articl…


Juan Manuel Aldana Reposted

Liver Transplantation in chronic liver disease and acute on chronic liver disease- Indication, Timing and Practices A comprehensive review by @ashok_doctor et al #LiverTwitter #Transplant doi.org/10.1016/j.jceh…

Tweet Image 1

Juan Manuel Aldana Reposted

❕Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter

Tweet Image 1

Juan Manuel Aldana Reposted

🤔 ¿Por qué se publican cada año tantas buenas revisiones sobre las peculiaridades de la coagulación en pacientes con #cirrosis? Respuesta corta: porque sigue haciendo falta explicarlo bien 🩸🔄 Fantástico artículo de @a_zanetto @marcosenzolo 👇 🔗 bit.ly/47EYOI0 en…

Tweet Image 1

Juan Manuel Aldana Reposted

*Video and images shown with full, written informed consent from the patient. Our first ESD of 2024, performed last week, using our saline-immersion technique (SITE)-facilitated, tri-tunnel variation of the pocket-creation method (PCM). The lesion was a 12 x 9cm laterally…


Juan Manuel Aldana Reposted

A nice review with data on pseudocirrhosis People with metastatic cancer to the liver can develop portal hypertension. 🔓open access 🔗link.springer.com/epdf/10.1007/s… #livertwitter

Tweet Image 1
Tweet Image 2

Juan Manuel Aldana Reposted

In the 📕#RedJournal: A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease Shannon Chang, MD, MBA; Megan Murphy, MD & Lisa Malter, MD, FACG 👉 bit.ly/47wJflG @shannonchangmd @MLongMD @JasmohanBajaj

Tweet Image 1

Juan Manuel Aldana Reposted

Sepsis is far too common for our patients with #cirrhosis That what makes studies like this one in @HepCommJournal so important 1️⃣lactate >2 as a high risk threshold 2️⃣MAP >65 in first 24 hours as a target Open access: journals.lww.com/hepcomm/fullte…

Tweet Image 1

Loading...

Something went wrong.


Something went wrong.